Philip Van Damme

Citée par

	Toutes	Depuis 2019
Citations	33648	23649
indice h	94	76
indice i10	334	307

4900

2450

1225

3675

2005200620072008200920102011201220132014201520162017201820192020202120222023202483 122 207 223 262 380 494 626 746 875 966 1117 1499 1893 2406 3122 3949 4440 4864 4741

Accès public

Tout afficher

331 articles

33 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Ludo Van Den BoschKU Leuven & VIBAdresse e-mail validée de kuleuven.vib.be
Koen Poesenprofessor, University of Leuven, KU Leuven, BelgiumAdresse e-mail validée de uzleuven.be
Orla HardimanTrinity College DublinAdresse e-mail validée de hardiman.net
Adriano Chio'Professor of Neurology, 'Rita Levi Montalcini' Department of Neuroscience, University of TurinAdresse e-mail validée de unito.it
Rik VandenbergheUniversity of LeuvenAdresse e-mail validée de uz.kuleuven.ac.be
Koen Van Laere, MD PhD DrScHoogleraar KU LeuvenAdresse e-mail validée de telenet.be
ammar al-chalabiProfessor of Neurology and Complex Disease Genetics, King's College LondonAdresse e-mail validée de kcl.ac.uk
Dietmar ThalProfessor for NeuropathologyAdresse e-mail validée de kuleuven.be
robin lemmensUZ leuven, KU LeuvenAdresse e-mail validée de vib-kuleuven.be
Peter De JongheVIB Department of Molecular Genetics, Neurogenetics Group, University of Antwerp, Institute BornAdresse e-mail validée de molgen.vib-ua.be
Louis De MuynckAdresse e-mail validée de its.jnj.com
Kristel SleegersVIB-Department of Molecular Genetics - University of AntwerpAdresse e-mail validée de molgen.vib-ua.be
Mamede de CarvalhoFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, PortugalAdresse e-mail validée de fm.ul.pt
Susanne PetriProfessorin für Neurologie, Medizinische Hochschule HannoverAdresse e-mail validée de mh-hannover.de
Maarten SchrootenDienst Neurologie, UZ LeuvenAdresse e-mail validée de uzleuven.be
Kim A. StaatsDirector of Rare Disease Drug Development, INmune BioAdresse e-mail validée de inmunebio.com
Sharon AbrahamsUniversity of EdinburghAdresse e-mail validée de ed.ac.uk
Peter Carmeliethoogleraar, Universiteit van Leuven, VIBAdresse e-mail validée de kuleuven.vib.be
Diether LambrechtsLaboratory for Translational Genetics, Department of Oncology, VIB and KULeuven, Leuven, BelgiumAdresse e-mail validée de vib-kuleuven.be
Steven BoeynaemsAssistant Professor, Baylor College of MedicineAdresse e-mail validée de bcm.edu

Suivre

Philip Van Damme

Professor of Neuroscience, University of Leuven

Adresse e-mail validée de uzleuven.be

ALS FTD progranulin C9orf72 TDP-43


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)–revised report of an EFNS task force EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis: European journal of neurology 19 (3), 360-375, 2012	1154	2012
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019	1022	2019
Amyotrophic lateral sclerosis: a clinical review P Masrori, P Van Damme European journal of neurology 27 (10), 1918-1929, 2020	909	2020
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017	653	2017
Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018	648	2018
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016	629	2016
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS E Storkebaum, D Lambrechts, M Dewerchin, MP Moreno-Murciano, ... Nature neuroscience 8 (1), 85-92, 2005	627	2005
The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis L Van Den Bosch, P Van Damme, E Bogaert, W Robberecht Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (11-12 …, 2006	616	2006
Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs J Jiang, Q Zhu, TF Gendron, S Saberi, M McAlonis-Downes, A Seelman, ... Neuron 90 (3), 535-550, 2016	597	2016
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease C d'Ydewalle, J Krishnan, DM Chiheb, P Van Damme, J Irobi, ... Nature medicine 17 (8), 968-974, 2011	575	2011
Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics S Boeynaems, E Bogaert, D Kovacs, A Konijnenberg, E Timmerman, ... Molecular cell 65 (6), 1044-1055. e5, 2017	531	2017
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ... New England Journal of Medicine 383 (2), 109-119, 2020	514	2020
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ... New England Journal of Medicine 387 (12), 1099-1110, 2022	492	2022
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018	489	2018
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival P Van Damme, A Van Hoecke, D Lambrechts, P Vanacker, E Bogaert, ... The Journal of cell biology 181 (1), 37-41, 2008	474	2008
HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients W Guo, M Naujock, L Fumagalli, T Vandoorne, P Baatsen, R Boon, ... Nature communications 8 (1), 861, 2017	371	2017
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans A Van Hoecke, L Schoonaert, R Lemmens, M Timmers, KA Staats, ... Nature medicine 18 (9), 1418-1422, 2012	364	2012
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology W Van Rheenen, RAA Van Der Spek, MK Bakker, JJFA Van Vugt, PJ Hop, ... Nature genetics 53 (12), 1636-1648, 2021	360	2021
Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018	341	2018
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis KP Kenna, PTC Van Doormaal, AM Dekker, N Ticozzi, BJ Kenna, ... Nature genetics 48 (9), 1037-1042, 2016	311	2016

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs